Locations
Pricing
Book Appointment
Book Appointment
Book Appointment

Diseases

Nisl quisque nunc gravida amet rhoncus arcu nulla arcu et. Hac arcu vel cras ornare mattis. Cum aliquam nullam pellentesque nec in. Mattis et senectus egestas enim. Nisl nibh in arcu ut.

Recurrent Pregnancy Loss (RPL)

Recurrent Pregnancy Loss (RPL) is typically defined as the occurrence of three or more consecutive pregnancy losses (miscarriages) before the 20th week of gestation. This condition is also referred to as recurrent miscarriage or habitual abortion. It affects approximately 1-2% of couples trying to conceive, although the exact cause can be difficult to pinpoint in many cases.

  • Chromosomal Abnormalities: One of the most common causes of RPL is chromosomal abnormalities in the embryos, often arising from either the egg or sperm. These can lead to issues like aneuploidy, where the embryo has too many or too few chromosomes, resulting in miscarriage.
  • Parent Chromosomal Translocations: In some cases, one or both parents may carry a balanced translocation, where parts of chromosomes are rearranged but not missing. This can cause an unbalanced chromosomal distribution in the offspring, leading to miscarriage.
  • Uterine Abnormalities: Structural problems in the uterus, such as a septate uterus (a partition in the uterus), fibroids, adhesions, or congenital malformations, can interfere with the implantation and growth of the embryo.
  • Cervical Insufficiency: A weakened or incompetent cervix that opens prematurely can lead to a late miscarriage, particularly in the second trimester.
  • Polycystic Ovary Syndrome (PCOS): Women with PCOS may have hormonal imbalances that affect ovulation, increasing the risk of miscarriage.
  • Thyroid Disorders: Both hypothyroidism and hyperthyroidism can interfere with pregnancy maintenance, increasing the likelihood of RPL.
  • Luteal Phase Defect: This condition which is not clearly defined, where the yellow body does not produce enough progesterone, can prevent the uterine lining from properly supporting the embryo.
  • Antiphospholipid Syndrome (APS): An autoimmune disorder where the body produces antibodies that can lead to blood clotting, increasing the risk of pregnancy loss.
  • Other Autoimmune Disorders: Conditions like lupus or rheumatoid arthritis can also increase the risk of miscarriage due to immune system abnormalities.

Certain infections, such as bacterial vaginosis or other sexually transmitted infections (STIs), could possibly increase the risk of miscarriage by affecting the uterus and surrounding tissues.

  • Smoking: Smoking is a well-established risk factor for miscarriage, as it can impair blood flow to the placenta and increase the risk of genetic abnormalities in the fetus.
  • Excessive Alcohol or Drug Use: Both can negatively affect pregnancy outcomes, including increasing the risk of miscarriage.
  • Obesity or Poor Nutrition: These factors can contribute to hormonal imbalances or other health problems that increase the likelihood of RPL.
  • Inherited or Acquired Blood Clotting Disorders: Conditions like Factor V Leiden or protein C deficiency can increase the risk of blood clots forming in the placenta, which can disrupt blood flow and possibly lead to miscarriage.

  • As a woman ages, the quality of her eggs declines, which can lead to an increased risk of chromosomal abnormalities and miscarriage.

     

Conclusion

The causes of recurrent pregnancy loss are multifactorial, and in many cases, no clear cause is identified. A thorough evaluation by a healthcare provider, including genetic testing, hormonal assessments, and imaging studies, is often necessary to determine the underlying reasons and guide treatment strategies. Treatment can vary depending on the cause and may involve interventions like hormonal therapy, surgery for anatomical issues, blood thinners, or lifestyle changes.

Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. It is a complex condition that affects various aspects of a woman’s health, including menstrual cycles, fertility, hormone levels, and metabolism.

Epidemiology

PCOS is estimated to affect 6-10% of women worldwide, making it one of the leading causes of infertility. It typically presents in adolescence or early adulthood, although the diagnosis may sometimes be delayed. The prevalence of PCOS varies by population and diagnostic criteria, but it is consistently found to be more common in women of Hispanic, Middle Eastern, and South Asian descent.

PCOS is often associated with other conditions like obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease. It is also a leading cause of anovulatory infertility, meaning women with PCOS may have difficulty ovulating and conceiving naturally.

Clinical Signs

One of the hallmark features of PCOS is irregular menstruation. Women with PCOS may experience infrequent periods (less than 8 cycles per year), or in some cases, may not menstruate at all (amenorrhea). This is due to anovulation (lack of ovulation), which occurs because of hormonal imbalances.

PCOS is often associated with other conditions like obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease. It is also a leading cause of anovulatory infertility, meaning women with PCOS may have difficulty ovulating and conceiving naturally.

Elevated levels of androgens (male hormones) are common in PCOS. This can result in:
  • Hirsutism: Excessive hair growth on areas where men typically grow hair, such as the face, chest, and back.
  • Acne: Increased androgen levels can contribute to oily skin and acne, particularly along the jawline and chin.
  • Alopecia: Thinning hair or male-pattern baldness can occur, especially on the scalp.

PCOS is often associated with other conditions like obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease. It is also a leading cause of anovulatory infertility, meaning women with PCOS may have difficulty ovulating and conceiving naturally.

As a result of anovulation, women with PCOS often struggle with infertility. Irregular or absent ovulation means that eggs are not released regularly, making it harder to conceive without medical assistance.

Many women with PCOS are overweight or obese, and they may have difficulty losing weight. Insulin resistance, where the body’s cells do not respond to insulin properly, is common in PCOS and can contribute to weight gain and difficulty losing weight. Insulin resistance is also a risk factor for the development of type 2 diabetes.

Other dermatologic symptoms of PCOS may include:
  • Acanthosis Nigricans: Dark, velvety patches of skin that typically appear in body folds (e.g., neck, armpits, groin).
  • Skin Tags: Small, benign growths that may appear in areas of friction, such as the neck or underarms.

Ultrasound Findings

One of the most characteristic features of PCOS is the presence of multiple small follicles in the ovaries
  • “String of Pearls” Appearance: On ultrasound, the ovaries of women with PCOS often display a “string of pearls” pattern, which refers to the appearance of numerous small follicles (usually around 2-9mm in diameter) arranged around the periphery of the ovary.
  • Enlarged Ovaries: The ovaries may be enlarged, typically measuring more than 10mL in volume. However, the size and number of cysts alone are not sufficient for a diagnosis of PCOS.
It is important to note that the presence of multiple ovarian follicles alone is not diagnostic of PCOS.

Biological (Laboratory) Signs

One of the key biological markers of PCOS is an elevated level of androgens, specifically testosterone. High testosterone levels can contribute to symptoms like hirsutism and acne. The levels of free testosterone or total testosterone can be measured through blood tests.

PCOS is often associated with other conditions like obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease. It is also a leading cause of anovulatory infertility, meaning women with PCOS may have difficulty ovulating and conceiving naturally.

  • Luteinizing Hormone (LH): A common finding in PCOS is an elevated LH-to-FSH (follicle-stimulating hormone) ratio, often greater than 2:1, with normal or low FSH levels. This imbalance contributes to the anovulation seen in PCOS.
  • Estrogen: While estrogen levels may be normal or mildly elevated, the lack of regular ovulation in PCOS can cause imbalances in estrogen and progesterone levels over time.
  • PCOS is often associated with other conditions like obesity, type 2 diabetes, metabolic syndrome, and cardiovascular disease. It is also a leading cause of anovulatory infertility, meaning women with PCOS may have difficulty ovulating and conceiving naturally.

Many women with PCOS have elevated insulin levels due to insulin resistance. Insulin resistance can lead to compensatory hyperinsulinemia, which may further increase androgen production by the ovaries and contribute to symptoms of PCOS. Elevated fasting insulin levels or impaired glucose tolerance may be found on lab tests.

Women with PCOS, especially those who are overweight or obese, may also have lipid abnormalities, including elevated levels of total cholesterol, triglycerides, and low HDL cholesterol. This increases their risk for cardiovascular disease.

Elevated prolactin levels or thyroid dysfunction can present with similar symptoms (e.g., irregular periods), so thyroid function tests and prolactin levels may be evaluated to rule out other conditions. However, prolactin levels are typically normal in PCOS unless another underlying issue is present.

Diagnostic Criteria

The diagnosis of PCOS is based on the Rotterdam Criteria (2003), which require the presence of at least two of the following three features:
  1. Oligo- or anovulation (irregular or absent periods).
  2. Clinical or biochemical signs of hyperandrogenism (e.g., hirsutism, elevated testosterone).
  3. Polycystic ovaries on ultrasound.
Other causes of menstrual irregularities, such as thyroid dysfunction or hyperprolactinemia, should be excluded before making a diagnosis of PCOS.

Conclusion

PCOS is a multifaceted disorder with a variety of clinical, ultrasound, and laboratory signs. While the exact cause is not fully understood, it is thought to be influenced by genetic, hormonal, and environmental factors. Women with PCOS may experience a range of symptoms, from menstrual irregularities to fertility issues, and they may also be at increased risk for metabolic disorders like type 2 diabetes and cardiovascular disease. Early diagnosis and management are key to improving quality of life and reducing long-term health risks associated with PCOS.

Endometriosis

Endometriosis is a chronic, often painful condition in which tissue similar to the lining of the uterus (endometrium) grows outside the uterine cavity. This tissue can implant on the ovaries, fallopian tubes, the outer surface of the uterus, and other pelvic organs, causing inflammation, scarring, and adhesions. Endometriosis is a leading cause of pelvic pain and infertility, affecting women of reproductive age.

Endometriosis affects approximately 10-15% of women of reproductive age worldwide, though its exact prevalence is difficult to determine, as many cases remain undiagnosed. It is estimated that around 30-50% of women with infertility are also affected by endometriosis. The condition can develop at any time during the reproductive years, typically beginning in the late teens to early 20s, but may also go undiagnosed until later in life. Endometriosis tends to be more common in women who have never been pregnant, and those with a family history of the condition are at a higher risk of developing it. Environmental and genetic factors are believed to contribute to its development, but the precise cause is not fully understood.

The symptoms of endometriosis vary widely and depend on the location and extent of the tissue growth. Some women with endometriosis may experience mild symptoms or none at all, while others suffer from debilitating pain and infertility. Common clinical features include:

  1. Pelvic Pain: One of the hallmark symptoms of endometriosis is chronic pelvic pain. This pain often worsens during menstruation (dysmenorrhea), but can also occur during intercourse (dyspareunia), bowel movements, or urination. The pain may be dull or sharp and can vary in intensity.
  2. Dysmenorrhea: Severe menstrual cramps are very common in women with endometriosis. This pain is typically felt in the lower abdomen and pelvis and may start before the onset of menstruation, lasting for several days.
  3. Infertility: Endometriosis is a leading cause of infertility, affecting approximately 30-50% of women with the condition. The mechanism behind this is not entirely clear, but it is thought that endometrial lesions may interfere with normal ovulation, fertilization, or implantation. Inflammatory factors and adhesions caused by the condition may also disrupt the fallopian tubes and ovaries.
  4. Dyschezia and Dysuria: Women with endometriosis may experience painful bowel movements (dyschezia) or painful urination (dysuria), particularly during menstruation. This occurs when the endometrial-like tissue invades the rectum or bladder.
  5. Other Symptoms: Endometriosis can also lead to fatigue, bloating, lower back pain, and gastrointestinal disturbances, including diarrhea, constipation, or nausea.

Ultrasound imaging is one of the first diagnostic tools used to evaluate suspected endometriosis, although it may not always detect the condition, particularly in cases where the lesions are small or deep within the pelvic cavity. However, ultrasound can be helpful in identifying certain signs:

  1. Endometriomas (Ovarian Cysts): These are cysts filled with old blood, often referred to as “chocolate cysts” due to their dark appearance in reality. Endometriomas are one of the most common findings in women with endometriosis and are typically located on the ovaries. On ultrasound, they appear with low-level echogenicity representing old blood in the cyst cavity (commonly termed ‘ground glass’).
  2. Adhesions or Fibrosis: Ultrasound may reveal signs of pelvic adhesions or fibrosis, which can occur when endometrial tissue causes organs to stick together. These adhesions can lead to pain and infertility by distorting the normal anatomy of the pelvic organs.
  3. Ultrasound Limitations: While ultrasound is useful for detecting ovarian endometriomas, it is less effective in diagnosing peritoneal or deep infiltrating endometriosis, which may be missed if no cysts are present.
MRI is considered a more advanced imaging modality for evaluating endometriosis, especially for detecting deep infiltrating disease and assessing the extent of the condition. MRI offers superior soft tissue contrast and can identify endometrial implants located in areas not easily seen on ultrasound, such as the bowel, bladder, or rectum. Typical MRI findings include:
 
  1. Endometriomas: On MRI, endometriomas appear as cystic masses with high signal intensity on T1-weighted images due to the presence of old blood, and low signal intensity on T2-weighted images.
  2. Deep Infiltrating Endometriosis (DIE): Deep infiltrating endometriosis, which involves the tissues more than 5 mm below the peritoneal surface, may involve the rectum, bladder, or bowel. MRI can reveal these deep lesions, which appear as areas of high signal intensity on T1-weighted images and low signal intensity on T2-weighted images.
  3. Bladder and Bowel Involvement: MRI is particularly useful for evaluating endometriosis involving the bowel and bladder, which are not easily seen with ultrasound. Lesions in these organs may cause symptoms such as dysuria and dyschezia.
  4. Pelvic Adhesions: MRI can help identify pelvic adhesions and determine the extent of organ involvement and distortion, providing valuable information for surgical planning.
There is no single laboratory test that can definitively diagnose endometriosis, but certain blood tests and markers can aid in the diagnosis or help assess the severity of the condition:
 
  1. CA-125 (Cancer Antigen 125): CA-125 is a protein that is often elevated in the blood of women with endometriosis, especially those with more severe forms of the disease. However, CA-125 is not specific to endometriosis and can also be elevated in other conditions, such as pelvic inflammatory disease, fibroids, or ovarian cancer. Elevated CA-125 levels should be interpreted in conjunction with clinical and imaging findings.
  2. Other Inflammatory Markers: Some studies suggest that other inflammatory markers, such as C-reactive protein (CRP) or interleukins, may be elevated in women with endometriosis, but these tests are not routinely used in clinical practice for diagnosis.
  3. Saliva Tests: New technology now allows women suffering from endometriosis to benefit from an early diagnosis. A French team of experts specialising in endometriosis has recently developed a saliva based diagnostic test that uses Next Generation Sequencing of microRNA’s with AI.
The gold standard for diagnosing endometriosis is laparoscopy, a minimally invasive surgical procedure where a camera is inserted into the pelvic cavity to directly visualize endometriotic lesions. During laparoscopy, tissue biopsies can also be taken for confirmation. However, due to the invasive nature of this procedure, laparoscopy is typically reserved for cases where the diagnosis is uncertain, or when surgical treatment is needed.
 
Management of endometriosis depends on the severity of the condition, symptoms, and the patient’s reproductive plans. Treatment options may include:
  • Pain management: Nonsteroidal anti-inflammatory drugs (NSAIDs) or hormonal therapies (e.g., birth control pills, progestins, GnRH agonists) to control symptoms.
  • Surgical intervention: Laparoscopic surgery can be used to remove endometriotic lesions, especially in women with infertility or severe symptoms.
  • Fertility treatment: Assisted reproductive technologies, such as in vitro fertilization (IVF), may be considered for women with endometriosis-related infertility.

Conclusion

Endometriosis is a complex and often debilitating condition that affects many women of reproductive age. Its clinical presentation can vary from mild discomfort to severe, chronic pain and infertility. Early diagnosis through a combination of clinical evaluation, imaging (ultrasound, MRI), and laboratory tests is essential for effective management. While there is no cure for endometriosis, a range of treatment options can help manage symptoms and improve the quality of life for those affected by the condition.

OATS (Oligo-Astheno-Terato-Spermia)

OATS stands for Oligo-Astheno-Terato-Spermia, a condition characterized by abnormalities in semen parameters that affect male fertility. It refers to a combination of three main sperm abnormalities:

Low sperm count, meaning the total number of sperm in the ejaculate is below the normal range.

Reduced sperm motility, meaning the sperm have poor or impaired movement, which can affect their ability to reach and fertilize the egg.

Abnormal sperm morphology, meaning a high percentage of sperm have an abnormal shape, which can impact their ability to penetrate the egg.

These abnormalities can result in male infertility, as they affect the sperm’s ability to fertilize the egg and achieve successful conception.

Causes of OATS: The causes of OATS are diverse and can involve a combination of genetic, environmental, lifestyle, and medical factors. Some of the most common causes include:

  • Klinefelter Syndrome: A genetic disorder where males have an extra X chromosome, leading to low sperm count, low testosterone, and infertility.
  • Y-chromosome Microdeletions: Small deletions in the Y chromosome, which can lead to poor sperm production and quality.
  • Cystic Fibrosis: A genetic condition that can cause blockages in the vas deferens, leading to a lack of sperm in the ejaculate (azoospermia).
  • Congenital Anomalies: Birth defects in the male reproductive system, such as undescended testes, can lead to sperm abnormalities.
  • Hypogonadism: A condition where the body doesn’t produce enough testosterone, leading to reduced sperm production.
  • Hyperprolactinemia: High levels of prolactin, a hormone that can interfere with testosterone production, negatively affecting sperm quality.
  • Thyroid Disorders: Both hypothyroidism and hyperthyroidism can disrupt sperm production and motility.
  • Testicular Dysfunction: Issues with the testicles, such as varicocele (enlarged veins in the scrotum), can lead to impaired sperm production and function.
  • Heat Exposure: Prolonged exposure to high temperatures (e.g., frequent use of hot tubs, saunas, or tight clothing) can damage sperm production in the testes.
  • Chemical and Pesticide Exposure: Exposure to toxins, heavy metals (like lead or mercury), and pesticides can harm sperm quality.
  • Radiation: Radiation therapy or prolonged exposure to radiation can reduce sperm count and motility.
  • Smoking: Tobacco use has been shown to reduce sperm count, motility, and morphology.
  • Alcohol Consumption: Excessive alcohol intake can disrupt hormone levels and impair sperm production.
  • Drug Use: Certain recreational drugs, such as marijuana or anabolic steroids, can negatively affect sperm parameters.
  • Obesity: Excess body fat can lead to hormonal imbalances, particularly elevated estrogen levels, which can impair sperm production.
  • Poor Diet: A diet lacking in essential nutrients, such as antioxidants and vitamins (like Vitamin C and Zinc), can contribute to poor sperm quality.
  • Chemical and Pesticide Exposure: Exposure to toxins, heavy metals (like lead or mercury), and pesticides can harm sperm quality.
  • Radiation: Radiation therapy or prolonged exposure to radiation can reduce sperm count and motility.
  • Sexually Transmitted Infections (STIs): Infections such as chlamydia, gonorrhea, and mumps (especially in adulthood) can lead to infertility by damaging the reproductive system.
  • Epididymitis

Ovarian insufficiency

Ovarian insufficiency, also known as primary ovarian insufficiency (POI) or premature ovarian failure, refers to a condition in which the ovaries stop functioning properly before the age of 40. This means that the ovaries fail to produce adequate amounts of estrogen and release eggs regularly, leading to irregular or absent menstrual cycles. The condition can result in infertility, as well as symptoms similar to menopause, such as hot flashes, night sweats, mood swings, and vaginal dryness.

The causes of ovarian insufficiency are varied. In some cases, it can be genetic, such as in conditions like Turner syndrome or Fragile X syndrome. Autoimmune diseases, infections, certain cancer treatments like chemotherapy, and surgeries removing the ovaries can also contribute to the condition. In many cases, however, the cause remains unknown.

Diagnosing ovarian insufficiency involves blood tests to measure hormone levels, including follicle-stimulating hormone (FSH) and estrogen. A high level of FSH combined with low estrogen often indicates that the ovaries are not functioning normally.

While there is no cure for ovarian insufficiency, treatments can help manage symptoms and improve quality of life. Hormone replacement therapy (HRT) is commonly prescribed to address estrogen deficiency and prevent complications like osteoporosis. For women struggling with infertility, options such as egg donation or in vitro fertilization (IVF) may be explored.

Living with ovarian insufficiency can be challenging, both physically and emotionally. It’s important for affected women to seek support from healthcare professionals, support groups, and loved ones to navigate the physical, mental, and emotional aspects of the condition.

Uterine myomas

Uterine myomas, also known as fibroids, are non-cancerous tumors that develop in or around the uterus. They are composed of muscle and fibrous tissue and can vary in size, ranging from small, asymptomatic growths to large masses that cause significant symptoms. Common symptoms of uterine myomas include heavy menstrual bleeding, pelvic pain, frequent urination, infertility and complications during pregnancy, such as miscarriage or preterm labor.

The exact cause of fibroids is not fully understood, but they are influenced by hormonal factors, particularly estrogen and progesterone. Family history, age, and ethnicity—especially in African-American women—also play a role in their development. Many women with fibroids experience few or no symptoms, while others may require treatment.

Treatment options for uterine myomas depend on the size, location, and severity of symptoms. Options range from medication to manage symptoms (such as hormonal therapies or pain relievers) to more invasive procedures, including uterine artery embolization, myomectomy (surgical removal of the fibroids), or, in extreme cases, hysterectomy (removal of the uterus).

Fibroids are common, affecting up to 70-80% of women by the age of 50, though many women with fibroids may not require treatment if their symptoms are mild. Regular monitoring and a personalized approach to treatment are essential for managing this condition effectively.

+972 58 63 68 585
jcohen.obgyn@gmail.com

Book Appointment

Privacy Policy / © SCW-Studio / All Rights Reserved

Facebook-f Instagram